Q2 2019 13F Holders as of 6/30/2019
-
Type / Class
-
Equity / Class A Common Stock, par value $0.01
-
Shares outstanding
-
316M
-
Number of holders
-
113
-
Total 13F shares, excl. options
-
95.3M
-
Shares change
-
-4.75M
-
Total reported value, excl. options
-
$683M
-
Value change
-
-$98M
-
Put/Call ratio
-
0.62
-
Number of buys
-
61
-
Number of sells
-
-83
-
Price
-
$7.17
Significant Holders of Amneal Pharmaceuticals, Inc. - Class A Common Stock, par value $0.01 (AMRX) as of Q2 2019
171 filings reported holding AMRX - Amneal Pharmaceuticals, Inc. - Class A Common Stock, par value $0.01 as of Q2 2019.
Amneal Pharmaceuticals, Inc. - Class A Common Stock, par value $0.01 (AMRX) has 113 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 95.3M shares
of 316M outstanding shares and own 30.15% of the company stock.
Largest 10 shareholders include Fosun International Ltd (19.6M shares), PRICE T ROWE ASSOCIATES INC /MD/ (18.7M shares), WELLINGTON MANAGEMENT GROUP LLP (14.4M shares), VANGUARD GROUP INC (9.76M shares), BlackRock Inc. (6.39M shares), TPG Group Holdings (SBS) Advisors, Inc. (3.88M shares), Point72 Asset Management, L.P. (3.32M shares), Neuberger Berman Group LLC (2.58M shares), STATE STREET CORP (2.13M shares), and NORGES BANK (1.35M shares).
This table shows the top 113 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.